AI news impact · China A-shares
Harbin Pharmaceutical Group Co., Ltd. Class A (600664) news impact
On 2026-11-03 Wave Radar's AI rated the news on Harbin Pharmaceutical Group Co., Ltd. Class A as neutral (impact score 0%).
Harbin Pharmaceutical appeared in a list of margin financing favorites, representing routine trading data without specific corporate or fundamental updates.
- Direction
- Neutral
- Impact score
- 0%
- Confidence
- 30%
- Headlines read
- 1
- Date
- 2026-11-03
AI assessment
Represents routine market margin trading statistics with no corporate fundamental development, likely resulting in a neutral impact.
Sector impact
No noticeable supply chain or peer sector impact.
Headlines the AI read
- 【数据揭秘】融资客看好个股一览 AkShare/证券时报网 · 2026-11-02
Rating history
One rating per trading day the stock was covered.
More on Harbin Pharmaceutical Group Co., Ltd. Class A
How the rating works
After each close Wave Radar collects the day's headlines and filings for a stock and asks an AI model what they mean for it. The rating is one of five levels from major negative to major positive; the impact score runs from −100% to +100%, and a rating built on a single uncorroborated source is capped. It describes the news, not the price outlook.
Figures are generated automatically from Wave Radar's published market data and refresh after each market close.